DETALII
Citeste mai mult
Descriere RO
This updated edition explores biosimilar drugs' strategic planning, focusing on legal matters, patents, regulatory pathways, and global affordability. It examines the science, technology, finance, ethics, and politics of biosimilars while presenting strategies for development and lifecycle management.
EdituraTaylor & Francis Ltd
Dimensiuni234 x 156
Data Publicarii08/12/2025
FormatCartonata
Numar pagini308
Aceasta este o carte in limba engleza. Descrierea cartii (tradusa din engleza cu Google Translate) este in limba romana din motive legale.